Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories
Open Access
- 20 October 2018
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 18 (1) , 1-10
Abstract
Antimicrobial resistance (AMR) is now recognized as a major threat to public health, and surveillance of AMR is essential for successful containment. In 2000, Japan Nosocomial Infections Surveillance (JANIS) Clinical Laboratory (CL) division has been launched as a voluntary AMR surveillance funded by the Ministry of Health, Labour and Welfare and managed by the National Institute of Infectious Diseases. In this study, we aimed to propose a model of sustainable national AMR surveillance which provides not only national AMR surveillance reports but also benchmarking reports to each hospital to facilitate infection control practices. JANIS CL division collects comprehensive specimen-based data complies with JANIS data format from participating hospitals each month. It had targeted only blood and cerebrospinal fluid samples but was expanded to all types of specimens in 2007 at revision of JANIS. The JANIS system interprets the antimicrobial susceptibility according to the same criteria and conducts removal of duplicates to allow accurate comparison between hospitals. Monthly feedback reports are created automatically within 48 h, while quarterly and annual reports are generated after data validation. At the beginning, 468 hospitals were enrolled in the JANIS CL division, but the number of hospitals that submitted data decreased to 210 (45%) in 2006. After surveillance revision in 2007, annual recruitment of hospitals was initiated and as of 2015, 1475 hospitals participated, and 1461 (99%) of them submitted data throughout the year. Nationwide surveillance data collected over the past decade revealed that the prevalence of methicillin-resistant Staphylococcus aureus has decreased since 2008, and that its prevalence is higher in the western part of Japan, where the number of hospitals per capita is higher than in the eastern part. JANIS CL division serves a model of sustainable national AMR surveillance system. Comprehensive data for all specimens promotes understanding of the sampling frequency and prevalence of AMR. As a well-established system for providing rich information to guide action both locally and nationally, JANIS may also be utilized for sharing AMR data globally.Keywords
Funding Information
- Japan Agency for Medical Research and Development (17fk0108307j0103)
- Japan Society for the Promotion of Science (15K08863)
This publication has 14 references indexed in Scilit:
- Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?PLOS Medicine, 2016
- Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013–2014European Journal of Clinical Microbiology & Infectious Diseases, 2016
- Surveillance of antibiotic resistancePhilosophical Transactions of the Royal Society B: Biological Sciences, 2015
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and OceaniaMicrobial Drug Resistance, 2015
- Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 yearsJournal of Antimicrobial Chemotherapy, 2012
- Infection Control in Healthcare Settings in JapanJournal of Epidemiology, 2012
- Recommendations For Metrics For Multidrug-Resistant Organisms In Healthcare Settings: SHEA/HICPAC Position PaperInfection Control & Hospital Epidemiology, 2008
- Active, Population‐Based Surveillance for Infectious Diseases2007
- Epidemics of Drug-Resistant Bacterial Infections Observed in Infectious Disease Surveillance in Japan, 2001-2005Journal of Epidemiology, 2007
- Surveillance of Antimicrobial Resistance: The WHONET ProgramClinical Infectious Diseases, 1997